At a glance
- Originator Roche
- Class Antineoplastics; Cyclohexanes; Hydroxycholecalciferols; Small molecules
- Mechanism of Action Vitamin D3 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Myeloid leukaemia
Most Recent Events
- 24 Jun 2001 No-Development-Reported for Myeloid leukaemia in USA (Unknown route)
- 13 Jan 1999 New profile
- 13 Jan 1999 Preclinical development for Myeloid leukaemia in USA (Unknown route)